Ganga Pharmaceuticals Limited informed the BSE Limited that it has received a certificate from KFin Technologies Limited, its Registrar and Share Transfer Agent (RTA), confirming dematerialization of shares and mutilation & cancellation of share certificates for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
